SkinHealth Systems Inc. SKIN
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 11.10% | -21.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.10% | -21.20% | |||
| Cost of Revenue | 11.25% | -30.20% | |||
| Gross Profit | 11.02% | -16.21% | |||
| SG&A Expenses | -1.73% | -11.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.74% | -18.85% | |||
| Operating Income | 298.33% | -1,211.73% | |||
| Income Before Tax | 78.56% | -41.72% | |||
| Income Tax Expenses | 756.52% | -105.58% | |||
| Earnings from Continuing Operations | 59.74% | 18.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.74% | 18.19% | |||
| EBIT | 298.33% | -1,211.73% | |||
| EBITDA | 150.16% | -35.88% | |||
| EPS Basic | 60.30% | 18.41% | |||
| Normalized Basic EPS | 81.61% | -62.09% | |||
| EPS Diluted | 62.00% | 14.77% | |||
| Normalized Diluted EPS | 81.09% | -57.63% | |||
| Average Basic Shares Outstanding | 1.41% | 0.28% | |||
| Average Diluted Shares Outstanding | -1.37% | 3.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||